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Corticotropin releasing factor (CRF) is a primary mediator of endocrine, autonomic
and behavioral stress responses. Studies in both humans and animal models have
implicated CRF in a wide-variety of psychiatric conditions including anxiety disorders
such as post-traumatic stress disorder (PTSD), depression, sleep disorders and addiction
among others. The central nucleus of the amygdala (CeA), a key limbic structure with
one of the highest concentrations of CRF-producing cells outside of the hypothalamus,
has been implicated in anxiety-like behavior and a number of stress-induced disorders.
This study investigated the specific role of CRF in the CeA on both endocrine and
behavioral responses to stress. We used RNA Interference (RNAi) techniques to locally
and specifically knockdown CRF expression in CeA. Behavior was assessed using the
elevated plus maze (EPM) and open field test (OF). Knocking down CRF expression in the
CeA had no significant effect on measures of anxiety-like behavior in these tests. However,
it did have an effect on grooming behavior, a CRF-induced behavior. Prior exposure to
a stressor sensitized an amygdalar CRF effect on stress-induced HPA activation. In these
stress-challenged animals silencing CRF in the CeA significantly attenuated corticosterone
responses to a subsequent behavioral stressor. Thus, it appears that while CRF projecting
from the CeA does not play a significant role in the expression stress-induced anxiety-like
behaviors on the EPM and OF it does play a critical role in stress-induced HPA activation.
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INTRODUCTION
Corticotropin releasing factor (CRF), also known as corticotropin
releasing hormone or corticoliberin, is a 41 amino acid peptide
(Vale et al., 1981) that plays an essential role in stress adapta-
tion and coping. It regulates a wide range of both acute and
chronic neuroendocrine, autonomic, and behavioral responses
(Koob and Bloom, 1985; Dunn and Berridge, 1990; Heinrichs
et al., 1995; Lehnert et al., 1998; Ronan and Summers, 2011).
Dysregulation of CRF signaling may be a common molecular
pathway for the myriad “stress-related” disorders. Measures of
hyperactivity of the CRF system have been consistently impli-
cated in the pathophysiology/etiology of a number of psychiatric
conditions including anxiety disorders such as PTSD as well as
depression and addiction (for reviews, see Arborelius et al., 1999;
Bale and Vale, 2004; Ronan and Summers, 2011). Understanding
the complexities of CRF regulated signaling and behaviors is
essential to understanding these psychiatric disorders.
Many studies have revealed a role for CRF and CRF1 recep-
tors in a range of stress responses. In animal models CRF (icv)
induces anxiety-like behavior and depressive symptoms, such as
anhedonia, decreased appetite, reduced slow wave sleep, psy-
chomotor alterations and reduced libido (Keck, 2006; Binder and
Nemeroff, 2010). The anxiogenic character of endogenous CRF
receptor ligands is verified by consistent anxiolytic effects of pep-
tide and non-peptide CRF1 antagonists (Zorrilla and Koob, 2004;
Holsboer and Ising, 2008), and by reduced anxiety-like behav-
ior in mice with a conditional knockout of limbic brain CRF1
receptors (Muller et al., 2003; Nguyen et al., 2006). Thus, during
stress CRF1 receptor signaling produces anxious behavior (Coste
et al., 2001; Risbrough et al., 2003, 2004, 2009; Bale and Vale,
2004; Heinrichs and Koob, 2004). Further results show decreased
responsiveness to stressful stimuli in constitutive transgenic CRF1
receptor knockout mice (Smith et al., 1998; Timpl et al., 1998;
Contarino et al., 1999). Together these findings suggested that
the CRF system would play an important role in depression and
anxiety disorders.
The central nucleus of the amygdala (CeA) is a key compo-
nent of an extended brain circuitry involved in stress responses
and anxiety-like behaviors and is an important structure for
CRF-mediated responses as it contains one of the highest con-
centrations of CRF immunoreactive neurons outside of the PVN
(Cummings et al., 1983; Swanson et al., 1983; Cassell and Gray,
1989; Shimada et al., 1989). Numerous studies have shown that
a wide variety of stressors and anxiogenic stimuli activate neu-
rons of the CeA as measured by increased expression of the early
immediate gene c-fos (Hayward et al., 1990; Campeau et al., 1991;
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Honkaniemi et al., 1992; Funk et al., 2003; Asok et al., 2013)
supporting the notion that stressors act, at least in part, through
the CeA. A vast neuroimaging literature has linked hyperrespon-
sivity of the amygdala to a range of anxiety and stress-induced
disorders such as PTSD (Liberzon and Sripada, 2008; Hughes
and Shin, 2011), addiction (Crunelle et al., 2012; Mihov and
Hurlemann, 2012; Goldman et al., 2013) and depression (Bellani
et al., 2011a,b). The CeA is the primary output of the amygdala.
Fibers from dense pyramidal CRF neurons located primarily in
the lateral part of the CeA project to other key regions includ-
ing lateral hypothalamus, lateral BNST, mesencephalic reticular
formation, locus ceruleus, raphé, ventral tegmental area, dorsal
and ventral parabrachial nuclei, mesencephalic nucleus of the
trigeminal nerve, core and shell ventromedial hypothalamus, ven-
tral subiculum, corticomedial amygdala (Cummings et al., 1983;
Sakanaka et al., 1986; Rodaros et al., 2007). Evidence suggests that
CeA CRF neurons play a role in HPA axis activation. Few fibers
from the CeA innervate the PVN directly (Sawchenko et al., 1993)
but fibers do heavily innervate PVN projecting structures such as
the BNST and very likely regulate the release of CRF from PVN
to the pituitary where it is the primary secretagogue of ACTH
causing HPA axis activation during stress (Choi et al., 2008).
Studies have suggested that CRF neurons in the CeA specif-
ically mediate a range of behavioral and endocrine responses
to stressors (Heinrichs et al., 1992; Heilig et al., 1994; Gray
and Bingaman, 1996). Stressors, both physical and psychologi-
cal, cause a rapid increase (within 1–3 h) in the expression of
CRF mRNA (Mamalaki et al., 1992; Kalin et al., 1994; Hsu
et al., 1998; Makino et al., 1999) and peptide (Makino et al.,
1999). Administration of CRF (icv) elicits anxiety-like behav-
iors that are attenuated by infusion of CRF antagonists into the
CeA (Heinrichs et al., 1992; Rassnick et al., 1993; Swiergiel et al.,
1993). This suggests that CRF neurons in the CeA are involved
in these behaviors since the majority of CRF in the CeA likely
arises from local circuits (Merlo-Pich et al., 1995). Studies uti-
lizing different animal models including rats, cats, and rabbits
have shown that electrical stimulation of the CeA causes auto-
nomic and anxiety-like responses mimicking those elicited by
stress that are identical to responses caused by icv CRF admin-
istration (Hilton and Zbrozyna, 1963; Mogenson and Calaresu,
1973; Stock et al., 1978). Microdialysis studies have demonstrated
local CRF release in the CeA during restraint stress (Merlo-Pich
et al., 1995). Increased release of CRF in the CeA is also impli-
cated as a potential mechanism underlying the anxiety associated
with withdrawal in drug and alcohol abuse (Menzaghi et al., 1994;
Merlo-Pich et al., 1995; Richter et al., 1995, 2000; Richter and
Weiss, 1999). Lesions of the amygdala block fear-conditioned star-
tle responses (Hitchcock and Davis, 1991). Bilateral lesions of the
CeA in rhesus monkeys reduced fear-related behavior and freez-
ing when exposed to an aversive stimulus and decreased levels of
cerebral spinal fluid CRF and plasma ACTH in response to the
stressor. This study showed that the CeA is involved in regulating
hypothalamic CRF activity, peripheral endocrine responses and
behavioral responses to fear-eliciting stimuli (Kalin et al., 2004).
More recently, studies on adult mice showed that site specific
manipulation of CeA CRF expression through lentiviral-based
systems affected behavioral and endocrine systems (Regev et al.,
2011, 2012; Flandreau et al., 2012) with sometimes contradic-
tory results. In contrast to the wealth of evidence pointing to a
role for CRF in the CeA in stress-induced anxiety-like behavior,
long-term (4month) viral-mediated overexpression of CRF in the
CeA actually reduced anxiety-like behaviors (Regev et al., 2011)
whereas long-term knockdown leads to decreases in anxiety-like
behavior and cortisol responses to acute stressors (Regev et al.,
2012).
Though a role of the CeA in stress and anxiety responses has
been extensively characterized, the specific contribution of CRF
neurons in the CeA to these responses has not. There are many
other neurotransmitter systems in the CeA that could be play-
ing a role including, among others, NPY and neurotensin. It has
been estimated that up to 90% of neurotensin labeled cells in the
CeA are also immunoreactive for CRF (Shimada et al., 1989).
Also, most studies implicating the CeA in stress responsiveness
have relied on stimulation or lesions; both of which could have
non-specific effects. For example, fibers projecting from the baso-
lateral amygdala to the BNST pass directly through the CeA. Some
have speculated that electrolytic lesions of this pathway account
for effects of what had been ascribed to CeA lesions (Davis et al.,
2010).
To further clarify the role of CRF in the CeA on anxiety-like
behavioral and corticosterone endocrine responses to stressors we
silenced expression of CRF in the CeA of adult rats using RNA
interference (RNAi). Our goal was to achieve a rapid localized
knockdown of CRF to limit possible compensatory upregulation
of other stress responsive systems that could mask the true role of
amygdalar CRF in these responses. We hypothesized that uncon-
ditioned anxiety-like behaviors and corticosterone responses to
stressors are mediated by CRF in the CeA and knocking down
CRF expression would be sufficient to attenuate these responses.
MATERIALS AND METHODS
ANIMALS
Adult male Sprague-Dawley rats (Charles River; 225–250 g)
were purchased from Charles River Breeders (CD-IGS Strain,
Wilmington, MA). Rats were housed 2 to a cage (24′ × 10′), given
free access to food and water and maintained on a 12:12 Light:
dark schedule with lights on at 7:00 am. Rats were acclimated for
at least 1 week before any procedures were carried out. All animal
procedures were carried out under an approved IACUC protocol
from the University of South Dakota in accordance with all appli-
cable rules and regulations in an AALAC approved facility at the
Sioux Falls VA Medical Center.
RNA INTERFERENCE
Short 21-mer double-stranded RNA oligonucleotides with TT
overhangs (siRNA) were synthesized (IDT DNA, Coralville, IA)
targeting the open reading frame of rat CRF mRNA (accession
number NM_031019). Multiple candidate 21-mer targets of the
CRF coding region of the CRF precursor gene were chosen using
the web-based SDS Program (siRNA Design Software; http://i.
cs.hku.hk/~sirna/software/sirna.php). This software tool makes
use of multiple existing design tools to output a set of ranked
candidate targets. These targets were further filtered based on
RNA secondary structure using the online bioinformatics site
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mfold Web Server (Zuker, 2003; http://mfold.rna.albany.edu/?
q=mfold/RNA-Folding-Form). The selected target sequence has
∼50 G-C content and is located within one exon (mRNA
nucleotides 697–716). A BLAST search confirmed uniqueness of
sequence.
Duplex sequences
Sense and antisense RNA strands were synthesized with 5′ tt
overhangs (IDT DNA, Coralville, IA). The siRNA oligonu-
cleotides were suspended in RNase-Free Duplex Buffer (IDT
DNA, Coralville, IA). GeneSilencer siRNA transfection reagent
(Gene Therapy Systems San Diego, CA) was mixed (1:1 ratio)
with the diluted siRNA oligonucleotides for a final siRNA concen-
tration of 3.3μg/μl. Themixture was allowed to incubate at room
temperature (RT) for 5min before it was loaded into a sterilized
RNase-free syringe.
SURGERY
Rats were anesthetized with isoflurane (2–2.5%; VetEquip
Inhalation Anesthesia System, Pleasanton, CA). Scalps were
shaved and rats were placed in a stereotactic apparatus (Kopf
model #900, Tujunga, CA) with the incisor bar set to −3.3 to
attain a flat skull position. Eye drops (LiquiTears™) were gently
applied throughout the surgery to prevent irritation and drying. A
Betadine scrub solution (provodone-iodine 7.5%) was applied to
the surgical area three times with fresh, sterile cotton swabs; each
time removed using sterile saline. A longitudinal incision was
made in the scalp and sterile tissue clamps were applied to expose
the skull. Fascia was scored and gently scraped with a scalpel. A
dilute hydrogen peroxide solution was applied to assist with stop-
ping any bleeding and it makes Bregma more visible. Stereotactic
coordinates were determined for the CeA (AP −2.1; ML ± 4.25;
DV −8.4; Paxinos and Watson, 1997) and holes drilled through
the skull with a sterile 0.7mm burr bit using a precision drill
(Foredom) attached to a stereotactic arm, being careful to leave
dura intact. With the aid of a surgical stereomicroscope, dura
and any remaining bone disc were very carefully removed using
a sterile 25-gauge needle. Sterilized 10μl syringes were filled with
either an siRNA duplex targeting CRF mRNA (siCRF) or scram-
bled sequence (siControl) diluted with transfection reagent as
described above. Syringes were placed in a microinjector unit
attached to the stereotactic frame (Model 5000/5001, David Kopf
Instruments, Tujunga, CA) and the syringe tip zeroed at the
brain surface. The syringe was then slowly (30–45 s) lowered to
the correct depth. The injections were made with a slow, steady
rate of injection (1.5μl/15min). This procedure was repeated on
the contralateral side of the brain using the same RNAi duplex.
For the dose response testing, the contralateral side of the brain
received the scrambled RNAi duplex. Bone wax was applied to
the drilled holes and the incision closed with staples (9mm
EZ Clips™). Triple antibiotic cream was applied to the wound
and the rat was placed in a cage with an absorbable lining and
a 125-Watt infrared heat lamp suspended over one end. Rats
were closely monitored until fully ambulatory. Rats were given
buprenorphine (0.01mg/kg SQ) and returned to their housing
unit where they were individually housed until experimental
procedures.
DOSE RESPONSE AND TIME COURSE OF THE siRNA
A preliminary dose and time course experiment was run to deter-
mine the lowest effective dose that could be used for behavioral
experiments. In order to evaluate the role of CRF in the CeA
on endocrine and behavioral responses to stressors and mini-
mize the potential for compensatory upregulation of other stress
systems we wanted to find the most effective dose with the
shortest latency to loss of peptide. Rats (n = 2/group) received
unilateral stereotactic injections of three different concentra-
tions of siRNA oligonucleotides were tested: 6.6μg/μl, 3.3μg/μl,
1.7μg/μl. One side received siRNA oligonucleotides targeting
CRF mRNA (siCRF) and the contralateral side received a scram-
bled sequence (siControl), into the CeA. Three different time
points were tested: 24, 48, and 72 h post-injection. Rats were killed
and brains removed for histological verification of both injection
site and quantification of CRF knockdown.
VERIFICATION OF CRF KNOCKDOWN
Immunohistochemistry
Immunostaining for CRF on brain sections containing the CeA
was performed. Rats were deeply anesthetized with isoflurane and
perfused transcardially with 300ml ice-cold saline (0.9%) with
heparin (200 units/l) followed by 300ml fresh 4% paraformalde-
hyde in 1X PBS using a gravity perfusion system. Brains were
removed, post-fixed in 4% paraformaldehyde overnight (24 h) at
4◦C then cryoprotected in 20% glycerol in 1X PBS before being
immersed in OCT compound (Tissue-Tek, Sakura) frozen sur-
rounded by powdered dry ice. Brains were sectioned at 35μm on
a cryostat microtome (chamber −25◦C, specimen −21◦C; Leica
CM 1900, Leica Microsystems; Wetzlar, Germany) and stored at
4◦C in 1X PBS with 0.01% NaAzide (Sigma, St. Louis, MO).
Sections containing the CeA were chosen with reference to an
atlas (Paxinos and Watson, 1997) washed twice for 5min each in
1X PBS then placed in blocking buffer (3% Normal Goat Serum,
0.25% Triton X-100 in 1X PBS) for 60–90min. Primary antibod-
ies were diluted with blocking buffer (CRF 1:1000, rabbit anti-rat
polyclonal cat# T-4037; Peninsula Labs, Belmont, CA; NeuN
1:500, mouse anti- rat monoclonal cat# MAB377; Millipore,
Billerica, MA). Sections were incubated overnight (∼18 h, free
floating) at RT with gentle agitation. The next day sections were
rinsed 3 × 3min in 1X PBS then incubated with fluorescently
labeled secondary antibody (Cy2 or Cy3 Goat anti-rabbit or
goat anti-mouse IgG; Jackson ImmunoResearch, West Grove, PA)
diluted 1:200 in 1X PBS and incubated at RT in darkness with
gentle agitation for 2–4 h. Sections were washed in 1X PBS three
times for 3min, mounted on poly-l-lysine coated and dried for
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2 h. Slides were then washed in 1X PBS followed by an ethanol
dehydration series (50, 75, 90, 100, 100% for 10 s each) and
the xylene substitute Citrisolv (Fisher) 2 × 3min before being
coverslipped with DPX mountant (Fluka).
Microscopy
A Zeiss Axioskop microscope equipped with an Axiocam color
camera was used to acquire digital images of CRF immunoflu-
orescence in CeA using a 20x objective from 3–4 tissue
sections from each animal. All images were acquired using
identical parameters. Acquisition settings were established to
prevent overexposure using native CRF immunoflourescence
from homecage rats. Images from coded slides were ana-
lyzed using Adobe Photoshop 7.0 (Adobe, Mountain View,
CA). Using a selection tool the CeA was manually selected
and average luminosity (intensity) level ± SD of the pixels
calculated using the histogram function. All values were nor-
malized for differences in background fluorescence by select-
ing a standardized unlabeled area adjacent to the CeA in
the same section. Corrected luminosity values were calcu-
lated by subtracting this background luminosity from lumi-
nosity in the CeA. These values were averaged for each
animal.
BEHAVIORAL TESTING
Separate cohorts of rats for open field (OF) and elevated
plus maze (EPM) testing were randomized into four groups
(n = 9–12/group): (1) No Stress-siControl, (2) No Stress-siCRF,
(3) Stress-siControl, and (4) Stress-siCRF. Separate cohorts were
used to enable us to decipher the effects of prior stress on
these behaviors. We were very cautious to control the amount
of prior stress the animals had since that was one of our exper-
imental conditions. Animals in the Stress groups were restrained
24 h prior to behavioral testing. Restraint stress was adminis-
tered for 1 h in commercial acrylic restraint tube with extra
ventilation holes. All testing was digitally recorded and analy-
sis performed with Ethovison XP software (Noldus Information
Technologies, Netherlands). Immediately following behavioral
testing rats were killed and brains removed for histological verifi-
cation of both injection site and knockdown of the CRF peptide
in CeA.
Elevated plus maze
Rats were placed in the center of the EPM and behaviors
recorded with a camera mounted on the ceiling for 5min.
Duration and frequency of open vs. closed arm entries along
with total locomotion were quantified using Ethovision soft-
ware. Other measures of exploratory and anxiety-like behav-
iors including head peaking (defined as breaking the plane of
the entrance to open arm with their body remaining in the
center), rearing and grooming were scored by two blinded
observers.
Open field
Rats were placed in the center of the OF (oval field, 61.0 ×
91.4 cm) and allowed to stay in the OF for 10min. Frequency
and duration of entries in the center zone along with rearing and
locomotion were measured.
PLASMA CORTICOSTERONE
Blood samples (∼25–50μl) were quickly collected (<30 s)
from the tail vein of rats using heparinized capillary tubes
after both restraint stress and behavioral testing as well as
from home cage control rats. Blood was centrifuged, plasma
collected and stored at −20◦C until assay. Corticosterone
concentrations were determined by ELISA (R&D Systems,
Minneapolis, MN).
STATISTICS
Corrected luminosity values of siCRF and siControl rats were
compared using an unpaired t-test. Data for corticosterone
and behaviors as dependent variables were analyzed by two-
way ANOVA (prior stress exposure X siRNA treatment) using
SigmaStat 3.0 (Systat Inc.). Pairwise comparisons were performed
using the Bonferroni post-hoc test. Significance level was set at
α = 0.05.
RESULTS
EFFECTIVENES OF siRNA KNOCKDOWN OF CRF
Decreased expression of CRF peptide with siRNA treatment
was evident across a wide range of doses (6.6μg/μl, 3.3μg/μl,
1.7μg/μl) and time points (24, 48, 72 h). Based on the
results from this preliminary investigation we chose to use
3.3μg/μl in these sets of experiments because it was the low-
est consistently effective dose at 48 h. Immunohistochemical
labeling of CRF and the neuron specific marker NeuN in
the CeA shows an almost complete siRNA-induced silenc-
ing of CRF expression without any loss of cells (Figure 1).
Figure 2 shows a representative image of the mechanical lesion
caused by the injector needle in the CeA. Corrected lumi-
nosity values of CRF immunofluorescence within the CeA
of control (siControl) and siCRF injected rats (Figure 3;
p < 0.00001).
PLASMA CORTICOSTERONE
As would be expected, home cage control rats had signif-
icantly lower concentrations of plasma corticosterone than
rats that were either restrained [F(6, 74) = 12.82; p < 0.00]) or
after behavioral testing [OF—F(4, 60) = 6.20; p < 0.001; Elevated
Plus—F(6, 74) = 6.63; p < 0.001] regardless of siRNA treatment
(Figures 4, 5). Prior stress had a significant main effect corticos-
terone levels [F(1, 74) = 14.91; p < 0.001] but RNAi treatment
alone did not [F(1, 74) = 0.90; p = 0.345]. There was a signif-
icant interaction of RNAi x Prior Stress [F(1, 74) = 7.40; p =
0.008]. Highest concentrations of corticosterone were found after
EPM testing in control rats that had been restrained the day
before. Knocking down CRF in the CeA blocked this heightened
corticosterone response (Figure 4; p < 0.05).
BEHAVIORAL TESTING
Open field
Knockdown of CRF in the CeA had no effect on locomotion
or measures of anxiety-like behavior in the OF. Total distance
traveled was not different between treatment groups [Figure 6;
F(3,50) = 0.94; p = 0.43]. Measures of anxiety-like behavior
included: frequency of entries into the center [Figure 7; F(3,50) =
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FIGURE 1 | Images (40X, Z-Scan) showing immunoreactivity for CRF
(green) and NeuN (red) in the CeA of siControl injected (A,B) and siCRF
injected CeA (C,D; 1.5µl, 3.3µg, 48h post-injection). Immunoreactivity
for CRF is robust in CeA of siControl injected while siCRF causes a
substantial decrease in CRF signal with no effect on number of neurons.
FIGURE 2 | Representative image (20X) showing injection needle tract
in CeA of a siControl injected animal. CRF neurons are labeled in green.
0.41; p = 0.75], duration of time spent in center [F(3,50) = 0.36;
p = 0.78] and rearing [F(3,50) = 2.17; p = 0.10].
Elevated plus maze
Standard measures of anxiety-like behavior on the EPM (% time
spent and % entries on open vs. closed arms) were not altered
by siRNA treatment [F(3, 41) = 1.23; p = 0.311 and F(3, 41) =
FIGURE 3 | Corrected luminosity (arbitrary units) of CRF
immunofluorescence within the CeA of control (scrRNA) and siRNA
injected rats. 1.5μl injections (3.3μg siRNA) of either scrambled siRNA
control or siRNA targeting CRF mRNA (∗p = 0.00001).
FIGURE 4 | Plasma corticosterone concentrations after restraint stress
and EP testing in siContol and siCRF rats. Restraint stress and EPM
induced a robust increase in corticosterone in both control and treatment
rats (p < 0.001). The highest concentrations of plasma corticosterone were
found after EPM testing in rats that had received restraint stress 24 h prior.
This restraint stress sensitization of corticosterone response to a
subsequent stressor was significantly attenuated by siRNA treatment
(p < 0.05).
0.98; p = 0.414, respectively]. Interestingly, frequency of open
entries was significantly increased by knocking down CRF expres-
sion in the CeA [F(3, 41) = 3.05; p < 0.05]. This measure does
not appear to be caused by increased locomotion as total dis-
tance traveled was not different significantly between groups
[F(3, 41) = 1.65; p = 0.20]. Time spent grooming was also sig-
nificantly attenuated by siRNA treatment regardless of prior
stress [F(3, 41) = 3.05; p < 0.05]. Rats that received CRF siRNA
(siCRF) groomed less than rats receiving siControl (Figure 8).
Prior stress had no effect on this parameter (40.4 s ± 12.3 and
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FIGURE 5 | Plasma corticosterone values after open field. Treatment
with siCRF and prior restraint had no significant effect on the increase in
plasma corticosterone induced by OF testing (p < 0.001).
FIGURE 6 | Distance traveled (cm ± SEM) in Open Field was not
significantly altered by siCRF treatment or restraint stress.
39.5 ± 7.7). Rearing [F(3, 41) = 1.669; p = 0.19] and number
of head peeks [F(3, 41) = 0.512; p = 0.68] were not affected by
treatment.
DISCUSSION
We sought to determine if CRF in the CeA plays a role in
stress-induced anxiety-like behaviors and HPA activation by
using RNAi techniques to locally and rapidly (within 2 days)
silence CRF expression in the CeA. This study demonstrates that
while CRF in the CeA plays a role in the expression of cer-
tain CRF-related behaviors and HPA responses, knocking down
amygdalar CRF expression is not sufficient to block the expres-
sion of anxiety-like behaviors on either the EPM or in the OF.
Grooming, a CRF-inducible behavior, was attenuated in siCRF
treated animals while measures of HPA activation (plasma cor-
ticosterone) were decreased by siCRF treatment animals with a
prior stress exposure.
FIGURE 7 | Number of entries into center (± SEM), a measure of
anxiolytic behavior, were not affected by siRNA treatment or restraint
stress.
FIGURE 8 | Grooming Behavior on the EPM (s ± SEM) was
significantly attenuated in rats with decreased CRF in CeA (p < 0.05).
Prior restraint stress had no effect on this behavior.
Prior exposure to a stressor sensitized an amygdalar CRF effect
on stress-induced HPA activation. In these stress-challenged ani-
mals silencing CRF in the CeA significantly attenuated corticos-
terone responses to a behavioral stressor. Corticosterone release
induced by restraint stress was not affected by treatment but was
significantly attenuated in siCRF animals in response to behav-
ioral anxiogenic stimuli 24 h after restraint. Thus, it appears that
the role of CRF in the CeA in mediating stress-induced HPA acti-
vation is context specific and demonstrates plasticity in response
to prior stress history. Activation of the CeA has been shown to
activate HPA axis (Herman et al., 2005). One possibility is an
indirect CRF activation of the BNST. CRF neurons in the par-
aventricular nucleus receive input from the CeA both directly
and indirectly through the BNST among other regions (Gray
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et al., 1989; Cullinan et al., 1993; Gray, 1993). However, direct
input from the CeA is minor compared to that of the BNST.
This anatomical evidence led to the proposal that the CeA influ-
ences the HPA axis via complex multisynaptic pathways that
likely include the BNST (Herman et al., 1994, 2005; Prewitt and
Herman, 1998). Interestingly, chronic overexpression of CRF in
the CeA (10 weeks) leads to increased expression of both CRF
and AVP in the PVN which correlated with increased measures of
HPA hyperactivity (Flandreau et al., 2012).
Restraint stress has been demonstrated to cause activation
and enhancement of CRF-mediated responses. It causes a rapid
increase in both CRF mRNA and peptide in neurons of the
CeA (Mamalaki et al., 1992; Kalin et al., 1994; Hsu et al., 1998;
Makino et al., 1999) and directly stimulates CRF release in the
CeA (Merlo-Pich et al., 1995). Prior restraint stress also causes a
suppression of exploratory behavior in a number of paradigms
that can be attenuated by CRF receptor antagonists (Berridge
and Dunn, 1987, 1989). Restraint stress increases CRF-enhanced
acoustic startle (Pelton et al., 1997) and markedly enhances CRF
induced firing of populations of dorsal raphe serotonergic neu-
rons (Lowry et al., 2000). This sensitization of CRF responses by
prior stressors has also been demonstrated for CRF-mediated sig-
naling specifically in the CeA. Administration of CRF (icv) alone
has no effect on serotonin signaling in the CeA, however, follow-
ing restraint (24 h prior) CRF significantly attenuated serotonin
release as measured by microdialysis and hplc in freely moving
rats (Ronan et al., 1999). In this experiment prior stress expo-
sure unmasked a role for CeA CRF knockdown in stress-induced
activation of the HPA and anxiety-like responses.
Another behavioral variable that is reliably increased by icv
CRF administration is locomotion (Dunn and Berridge, 1990;
Koob, 1999; Lowry et al., 1996). In our study, decreases in CeA
CRF did not significantly alter locomotion either in the OF or
on the EPM. In agreement with our findings two other studies
found no effect of long-term viral mediated amygdalar CRF over-
or underexpression on locomotion in homecage environments
(Regev et al., 2011, 2012). Other studies, however, have sug-
gested an inhibitory role of amygdalar CRF on locomotion. Rats
treated with corticosterone early in development had decreased
numbers of CRF-immunopositive neurons in the CeA and this
correlated with increased locomotion (Roskoden et al., 2005). It
is difficult to ascribe a central role of CRF to this altered loco-
motion since there are certainly many other systems that could
contribute that would have been altered by early exposure to
corticosterone. More recently, specific viral-mediated overexpres-
sion of CRF in the amygdala also led to decreased locomotion
in the OF but not other tests leading the authors to postu-
late that amygdalar CRF does not cause a locomotor deficit
but rather a “psychomotor retardation in a novel environment”
(Flandreau et al., 2012). Together with our findings the evi-
dence points to no significant role of amygdalar CRF on baseline
locomotor activity.
Our results only partially support the literature suggesting a
central role for CRF in the CeA with the expression of anxiety-like
behavior and the hypothesized central role of CRF in stress-
induced anxiety disorders (Davidson, 2002; Schwartz et al., 2003;
Ronan and Summers, 2011). Inhibiting expression of CRF in the
CeA had no effect on standard measures of anxiety-like behav-
iors on the EPM (% time or % entries on the open vs. closed
arms) or in the OF (% time in center). In this experiment, groom-
ing behavior on the EPM was significantly attenuated by loss
of CRF in CeA regardless of whether or not animals had been
previously exposed to restraint stress. Grooming behavior on the
EPM is often used as a corollary measure of anxiety-like behav-
ior (Bolanos et al., 2003; Estanislau, 2012; Tapia-Osorio et al.,
2013), however, this is not universally accepted (Bolles, 1960;
van Erp et al., 1994). Self-grooming is a behavioral response in
rodents to stressful or anxiogenic stimuli (Spruijt et al., 1992).
Central administration of CRF (icv) has long been known to
cause increased grooming behavior (Dunn et al., 1987). This
study highlights the important role of amygdalar CRF in this
behavior. The significance, if any, of the finding that on the EPM,
siCRF treatment rats had significantly more open entries than
controls is unclear. When normalized to number of closed entries
this significance is lost. Perhaps it is simply an expression of
increased motor activity, though total locomotion did not differ.
Or it could be indicative of an increase in exploratory behavior.
Thus, knocking down CRF in the CeA alters some stress-induced
behaviors it is not sufficient to completely attenuate anxiety-like
responses.
Even though there is a wealth of evidence suggesting an
anxiogenic role for CRF and the amygdala it is likely that
CRF-mediated anxiety-like behaviors, like that hypothesized for
endocrine responses, are mediated in part by other brain regions
as well. Studies in rats, cats, and rabbits have shown that electri-
cal stimulation of the CeA causes anxiety-like responses (Kaada
et al., 1954; Hilton and Zbrozyna, 1963; Heinemann et al., 1973;
Mogenson and Calaresu, 1973) and conversely, lesions of the CeA
attenuate anxiety-like responses (Moller et al., 1997; Kalin et al.,
2004). The primate amygdala plays a role in certain anxiety-
like behaviors such as anxiety-related defensive responses, which
may have a conditioned fear component (Kalin et al., 2004). The
amygdala has been implicated in anxiety responses in a novel
environment such as the EPM. However, amygdala lesions do not
affect anxiogenic responses on the EPM except in rats that had
received restraint stress (Moller et al., 1997).
It has been suggested that the CeA may be more spe-
cific to conditioned anxiety or fear, whereas the BNST may
be more involved in unconditioned anxiogenic effects (Walker
and Davis, 1997; Davis and Shi, 1999; Davis et al., 2010).
The BNST and the CeA are anatomically, neurochemically,
cytoarchitecturally, and embryologically related (Alheid and
Heimer, 1988). The BNST is considered a site of conver-
gence of information from brain regions associated with the
control of emotional, cognitive, autonomic and behavioral
responses related to stress. (Alheid and Heimer, 1988; Casada
and Dafny, 1993a,b; Ciriello and Janssen, 1993; Cullinan et al.,
1993). The lateral subdivision of the anterior BNST, contain-
ing high concentrations of CRF neurons is extensively connected
with several brain areas that coordinate autonomic, neuroen-
docrine and behavioral responses to stress, such as a recipro-
cal connection with the CeA, parabrachial nucleus and PVN
(De Olmos and Ingram, 1972; Moga et al., 1989; Moga and Saper,
1994; Dong et al., 2001; Dong and Swanson, 2004).
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The involvement of CRF systems in both the BNST and CeA
has been demonstrated for other stress-induced behaviors. CRF
systems in both the CeA and BNST appear to be involved in
stress-induced relapse to cocaine seeking behavior in rats. CRF
microinfusions into the BNST but not the CeA mimic the effects
of footshock on reinstatement (Erb et al., 2001). Also, infusions
of the CRF1 antagonist D-Phe CRF12−41 into the CeA are inef-
fective at blocking reinstatement but doses 10-fold lower in the
BNST are capable of blocking the behavior. Lesions of the CeA
lead to an attenuated reinstatement but do not block the behav-
ior completely. Together these findings suggest a role for the
CRF-containing pathway from the CeA to the BNST in stress-
induced reinstatement but CRF release in the BNST appears to
be the critical factor controlling this behavior. This release could
be both from fibers originating in the CeA as well as from local
circuits in the BNST. Another behavior mediated by CRF sys-
tems in both the CeA and BNST is fear-potentiated acoustic
startle. The acoustic startle reflex is an unconditioned response
to a loud noise. The startle reflex that is elicited by noise in a
non-paired context can be increased in amplitude if the startle
noise is given in the presence of a cue that has been previously
paired with shock (Brown et al., 1951; Davis and Astrachan, 1978;
Davis, 1990; Yeomans and Pollard, 1993). Electrolytic lesions of
either the amygdala (Hitchcock and Davis, 1986) or the amyg-
dalofugal pathways (Hitchcock and Davis, 1987) can block this
fear potentiated startle but not the startle response itself. The
direct pathway from the amygdala to the nucleus reticularis pontis
caudalis was originally proposed as the critical pathway mediat-
ing fear-potentiated startle (Hitchcock and Davis, 1991). Further
studies have demonstrated that this pathway is not direct. It
is relayed by a synapse in the rostral midbrain (Yeomans and
Pollard, 1993; Zhao and Davis, 2004). Injections of CRF (icv)
can also enhance acoustic startle response in a non-paired con-
text. This effect is mediated by the BNST. Lesions of the BNST
but not CeA block CRF-mediated potentiation of acoustic star-
tle. Also, CRF microinjected into BNST but not CeA mimics the
effects of icv CRF and CRF antagonists in the BNST block CRF
enhanced startle (Lee and Davis, 1997). Though the CeA is crit-
ical to the expression of fear-potentiated startle it is not critical
to the expression of CRF enhanced startle. Much like the story
with stress-induced relapse, it appears that the effects of CRF are
mediated in the BNST, at least in part by a CRF pathway from the
CeA. Thus, it is likely that activation of the BNSTmay be a critical
output for behavioral responses.
In conclusion, CRF in the CeA certainly contributes to
the expression of endocrine responses to stressors but has
much less effect on behavioral responses. Silencing CRF expres-
sion in the amygdala attenuates a heightened HPA activa-
tion in response to a behavioral stressor in animals with
prior stress exposure. Unconditioned stress-induced anxiety-
like behavioral responses are attenuated by loss of CRF in the
CeA in animals regardless of stress history. However, knock-
ing down expression of CRF in the CeA is not sufficient to
completely block expression of anxiety-like responses suggest-
ing that amygdalar CRF is part of a wider response coordi-
nated by this and other brain regions/neurotransmitter systems.
This study adds further weight to the body of evidence link-
ing CRF signaling to stress-induced anxiety disorders and helps
to clarify the specific contribution of amygdalar CRF to stress
responsiveness.
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